Authors
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
New Frontiers in Biosimilar PathwaysUS manufacturers prepare for expanding biosimilar market opportunities as this exciting landscape takes shape. The production of biosimilars poses challenges as pharma looks to curb health care spending.
Latest:
Creativity in the WorkplaceIs Mad Men illustrating that one cannot be creative in their daily workflow?
Latest:
Medication Formulary Management in a Large, Multihospital SystemClarian Health, an 11-hospital health system, developed and managed a multihospital formulary through focused planning and collaboration.
Latest:
Current and Emerging Therapeutics in Cystic Fibrosis: Ensuring Continuity of Care within the New Treatment ParadigmThis Continuing Education activity is supported by an educational grant from Vertex Pharmaceuticals, Inc.
Latest:
Tips for Finding the Perfect Residency MatchThe goal of the residency interview is to find the right fit.
Latest:
Flipping the Script: The Complexities of the Health Care System and the Importance of Cancer Care ManagementAll stakeholders in the health care continuum should always remember that there is a person at the end of their businesses who depends on them to survive and have a high quality of life.
Latest:
State-Level Confidentiality for Compounding Pharmacies Preparing Medications to Be Used in Lawful ExecutionsFollowing in the footsteps of its subsidiary hospira inc, Pfizer is the latest, and largest, pharmaceutical company to take a stand against its products being used for lethal injection.
Latest:
PGY-1 Resident Finds Niche in Geriatrics PharmacyAn Interview with Dr. Hien Nguygen, a PGY-1 Resident at Penn Medicine Lancaster General Health who has a love for geriatric pharmacy
Latest:
Making Lemonade out of Lemons: Fighting the Opiate EpidemicWe pharmacists have found ourselves stuck in the crossfire of a national opiate epidemic.
Latest:
Community-Acquired PneumoniaCommunity-acquired pneumonia (CAP) is defined as pneumonia acquired outside hospital or health care facilities.
Latest:
States Grant Prescribing Authority to PsychologistsThis movement has aimed to address the mental health care epidemic in the United States.
Latest:
HIV PEP Therapy: Is the United States Holding Back?Inspired by her volunteer work at an AIDS foundation, a pharmacy student investigates HIV PEP therapy across 3 continents.
Latest:
Annual Stroke Costs to Health Plans Among Atrial Fibrillation PatientsAn incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
Latest:
A Closer Look at New FDA Actions Merck's DuleraDulera (mometasone furoate and formoterol dehydrate) Inhalation Aerosol is FDA-approved for the treatment of asthma in patients aged 12 and older.
Latest:
The Importance of MentoringPharmacy students need to understand the value of mentoring and seek a quality mentor while still in school. Here are some guidelines for establishing this vital support system.
Latest:
Telepharmacy and Its Impact on Formulary AdherenceTelepharmacy is comparable to usual care in transitioning members new to an HMO onto formulary medications.
Latest:
Predictors of Healthcare Costs After Initiating Dabigatran Versus WarfarinThe study found no mean difference in all-cause healthcare costs for patients with newly diagnosed nonvalvular atrial fibrillation initiating treatment with dabigatran versus warfarin.
Latest:
Pharmacy's Societal Mission and the Need for a ForumMr. McAllister is a health-systems consultant based in Chapel Hill, NC.
Latest:
Therapeutic Interchange of Carvedilol to Bisoprolol for Chronic Heart Failure: The Singapore ExperienceA carvedilol to bisoprolol interchange program was carried out in a Singapore hospital with substantial cost savings of US$116 per patient-year without increase in adverse outcomes.
Latest:
Cost-Effectiveness of Docetaxel-Cyclophosphamide Versus Doxorubicin-Cyclophosphamide for Breast CancerCompared with doxorubicin plus cyclophosphamide, docetaxel plus cyclophosphamide was highly cost-effective for adjuvant treatment of operable breast cancer.
Latest:
The Expanding Health Benefits of Prebiotics and ProbioticsA Continuing Education program, featured in the February 2018 issue of Pharmacy Times.
Latest:
Emergent Management of Ischemic Stroke: Treatment ABCsStroke affects nearly 700,000 Americans a year. Emergency management is key to a positive patient outcome.
Latest:
Total Health Care in Aisle 5Pharmacy jobs at grocery chains offer pharmacists regular contact with their patients, a positive work environment, and a total health care approach to their pharmacy practice.
